The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gemcitabine Response in Advanced Breast Cancer in Relation to Immunohistochemical Factors.
 
Masatoshi Kudo
Honoraria - Ajinomoto; Bayer; Eisai; MSD
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Chugai Pharma; Kowa; MSD; Taiho Pharmaceutical
Research Funding - Abbvie; Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; MSD; Otsuka; Sumitomo Dainippon; Taiho Pharmaceutical; Takeda
 
Jean-Luc Raoul
Honoraria - Bayer; Merck Serono; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer Schering Pharma; BTG; Taiho Pharmaceutical
Research Funding - Celgene (Inst)
 
Han Chu Lee
Consulting or Advisory Role - Bayer
Research Funding - Bayer
 
Ann-Lii Cheng
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Merck Serono; Novartis; Ono Pharmaceutical; ONXEO
Speakers' Bureau - Novartis
Research Funding - Sanofi
 
Keiko Nakajima
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Honoraria - Kyowa Hakko Kirin (I)
Travel, Accommodations, Expenses - Kyowa Hakko Kirin (I)
 
Markus Peck-Radosavljevic
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Research Funding - Bayer
Expert Testimony - Bayer